Stephen R. Bertenshaw

Author

Monsanto (United States)

Also Known As

Bertenshaw, S., S Bertenshaw, S. BERTENSHAW, S. R. BERTENSHAW, Stephen Bertenshaw, Stephen R. Bertenshaw

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Monsanto (United States)University of Illinois Chicago Bristol-Myers Squibb (United States)

About

Stephen R. Bertenshaw is an author at Monsanto (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	405
2	Natural Sciences	6	6	326
3	Biochemistry	5	5	106
4	Engineering	2	2	87
5	Biomedical Engineering	1	1	24

Stephen R. Bertenshaw

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib) Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw, Journal of Medicinal Chemistry	1997	1.9K
<i>N</i>-[[(5-Methyl-3-phenylisoxazol-4-yl)- phenyl]sulfonyl]propanamide, Sodium Salt, Parecoxib Sodium: A Potent and Selective Inhibitor of COX-2 for Parenteral Administration John J. Talley, Stephen R. Bertenshaw, David Brown, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical Chemistry	2000	211
Phosphine mediated synthesis of 2-methylidene-3-amino esters and ketones Stephen R. Bertenshaw, Michaël Kahn Tetrahedron Letters 2-Methylidene-3-amino EstersEngineeringOrganic ChemistryStereoselective SynthesisSynthetic Chemistry	1989	63
Effect of Phosphoramidon (Endothelin Converting Enzyme Inhibitor) and BQ-123 (Endothelin Receptor Subtype A Antagonist) on Blood Pressure in Hypertensive Rats Ellen G. McMahon, Maria A. Palomo, Melanie A. Brown, American Journal of Hypertension Lower MapHypertensionCardiovascular DiseaseRenal Artery-ligated RatMedicine	1993	46
Conformationally restricted 1,5-diarylpyrazoles are selective COX-2 inhibitors Stephen R. Bertenshaw, John J. Talley, D. Joseph Rogier, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineRational Drug DesignSelective Cox-2 InhibitorsAnti-cancer Agent	1996	42
Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency Stephen R. Bertenshaw, Roland S. Rogers, Michael Stern, Journal of Medicinal Chemistry Altmetric Attention ScoreSystem PharmacologyPharmaceutical ChemistryPre-clinical PharmacologyTranslational Pharmacology	1993	34
The incorporation of β-turn prosthetic units into merrifield solid phase peptide synthesis Michaël Kahn, Stephen R. Bertenshaw Tetrahedron Letters EngineeringPeptide Engineeringβ-Turn Prosthetic UnitsPeptide SynthesisPeptide Science	1989	24
(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents Li‐Qiang Sun, Katherine S. Takaki, Jie Chen, Bioorganic & Medicinal Chemistry Letters Melatoninergic AgentsMedicinal ChemistryDerivative (Chemistry)Natural SciencesOrganic Chemistry	2005	22
ChemInform Abstract: Synthesis and Biological Evaluation of the 1,5‐Diarylpyrazole Class of Cyclooxygenase‐2 Inhibitors: Identification of 4‐(5‐(4‐Methylphenyl)‐3‐ (trifluoromethyl)‐1H‐pyrazol‐1‐yl)benzenesulfonamide (SC‐58635, Celecoxib). Thomas D. Penning, J. J. TALLAY, Stephen R. Bertenshaw, ChemInform Weekly Abstracting ServiceBiochemistryMedicineAbstract CheminformNatural Sciences	1997	21
Peptide mimetics of the thrombin-bound structure of fibrinopeptide A. Hiroshi Nakanishi, R. Alan Chrusciel, Richard Shen, Proceedings of the National Academy of Sciences Peptide MimeticsProtein AssemblyBiochemistryProtein FoldingNatural Sciences	1992	20

Page 1